1-methyl-1,2,3,4-tetrahydro-beta-carboline-3-carboxylic acid has been researched along with gastrin 17 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hellström, PM; Hendolin, P; Kaihovaara, P; Kronberg, L; Meierjohann, A; Millerhovf, A; Paloheimo, L; Salaspuro, M; Sundelin, H; Syrjänen, K; Webb, DL | 1 |
1 trial(s) available for 1-methyl-1,2,3,4-tetrahydro-beta-carboline-3-carboxylic acid and gastrin 17
| Article | Year |
|---|---|
Slow-release L-cysteine capsule prevents gastric mucosa exposure to carcinogenic acetaldehyde: results of a randomised single-blinded, cross-over study of Helicobacter-associated atrophic gastritis.
Topics: Acetaldehyde; Adult; Carbolines; Carcinogenesis; Cross-Over Studies; Cysteine; Delayed-Action Preparations; Ethanol; Female; Gastric Juice; Gastric Mucosa; Gastrins; Gastritis, Atrophic; Helicobacter; Humans; Male; Middle Aged; Single-Blind Method; Stomach Neoplasms; Sweden | 2017 |